Rockwell Medical Inc. (RMTI)
NASDAQ: RMTI
· Real-Time Price · USD
1.20
0.00 (0.00%)
At close: Oct 15, 2025, 3:59 PM
1.21
0.83%
After-hours: Oct 15, 2025, 04:31 PM EDT
0.00% (1D)
Bid | 1.17 |
Market Cap | 41.32M |
Revenue (ttm) | 87.97M |
Net Income (ttm) | -2.1M |
EPS (ttm) | -0.07 |
PE Ratio (ttm) | -17.14 |
Forward PE | -8.77 |
Analyst | Buy |
Dividends | n/a |
Ask | 1.22 |
Volume | 514,461 |
Avg. Volume (20D) | 1,407,207 |
Open | 1.20 |
Previous Close | 1.20 |
Day's Range | 1.19 - 1.23 |
52-Week Range | 0.78 - 5.15 |
Beta | 1.73 |
Ex-Dividend Date | n/a |
About RMTI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RMTI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RMTI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsRockwell Medical Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+16.84%
Rockwell Medical shares are trading higher after t...
Unlock content with
Pro Subscription
5 months ago
-7.14%
RMTI stock has given up its prior gain. Rockwell Medical shares were trading higher after the company reported better-than-expected Q1 financial results.

16 hours ago · businesswire.com
Rockwell Medical to Release Third Quarter 2025 Results on Wednesday, November 12, 2025WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2025 on Wednesday, November 12, 2025.